loading

Recent events

GLuna Shrimp owner Gabriel Luna

AdvertisementX
AdvertisementX

Aquatech

Fish health firm Aqua Pharma buys stake in UK lice treatment startup

Aqua Pharma has acquired a 50% stake in developer Pulcea for a six-figure sum with the intention of commercializing its use of sound energy in sea lice treatments

By Undercurrent News | May 15, 2020 09:48 BST
Scottish salmon being checked for sea lice
Related

Mowi orders one of industry’s largest de-licing vessels

Scientist warns ‘Thermolicer’ devices contravene welfare standards

Rendering of the Thermolicer "system V" in action. Credit: Steinsvik

SSPO welcomes latest Scottish gov’t regulations on medicines

No size changes planned for salmon harvests as big fish prices drop below small

Cermaq salmon

Five US seafood ports to be hit hardest by new strike threat

Peruvian fishmeal market ‘very active’ as season unfolds

AdvertisementX

The Norwegian aquaculture health firm Aqua Pharma says it has acquired a 50% stake in Scottish lice treatment developer Pulcea for a six-figure sum [...]

Want to keep reading?

Sign up for a trial to have full access to our articles for 7 days!

Canadian lobster industry worried about potential US tariffs

NGO plans to sue Cooke over alleged water pollution by Maine salmon farms

NOAA to propose seafood import monitoring expansion again, acknowledge forced labor

Canada’s Beothic Fish Processors denies sale rumors, too

AdvertisementX

Stay on the pulse

Get recommendations, data, editor’s picks, and the latest news from around the seafood world straight to your inbox.

Select your interests

Please select at least one newsletter d indicates our daily newsletters | 2w indicates twice-weekly | All others sent weekly All briefings are sent weekly, unless otherwise indicated
Region
Breaking news
Jobs
Species
Topic

Fill in your details

Please select at least one newsletter!
  • (eg new industry reports, prices data)
  • (eg subscription or report early birds)
  • (eg advertising, trade shows news)
How we handle your data We never share, sell or distribute our subscribers’ data. You may at any time unsubsribe from our newsletters, and request that we erase all information stored about you. Please check our Privacy policy for more details.

We use MailChimp and HubSpot as our email campaign platforms. By subscribing, you agree that the information you provide will be transferred to MailChimp and HubSpot for processing in accordance with their privacy policies (MailChimp privacy policy, HubSpot privacy policy) and terms (MailChimp terms, HubSpot terms).

Thank you. Please check your inbox to confirm your selection and start receiving newsletters.

Cookies on Undercurrent News

We use cookies for performance, security and analytics. To stop seeing this banner click Accept, or select Manage cookies to set your preferences and privacy settings.